New York Presbyterian


This is your central portal for breaking news, the latest research and important updates from New York-Presbyterian. Bookmark this page and check back often for updates.


Should physician advocacy be a core component of medical professionalism?

Orthopedics Today, January 2020
An online search shows advocacy is defined as “public support for or recommendation of a particular cause or policy.” Therefore, it goes…
Meeting NewsPerspective

Neoadjuvant pembrolizumab benefits patients with high-risk triple-negative breast cancer

December 12, 2019
SAN ANTONIO — The addition of pembrolizumab to neoadjuvant chemotherapy and as adjuvant therapy increased pathologic complete response among…
Meeting NewsPerspective

Bispecific CAR T-cell therapy safe, effective for advanced multiple myeloma

December 7, 2019
ORLANDO — More than 90% of patients with relapsed or refractory multiple myeloma responded to therapy with a bispecific chimeric antigen…
Meeting News

ASTRO honors three Gold Medal recipients

September 22, 2019
The American Society for Radiation Oncology honored three of its members with the Gold Medal Award. This year’s recipients were Walter J
Meeting News

Researchers identify mutations associated with treatment sensitivity, resistance in NSCLC

September 8, 2019
BARCELONA —STK11 and KEAP1 mutations appeared associated with poorer outcomes among patients with
In the JournalsPerspective

Dabrafenib-trametinib combination confers durable survival benefit in BRAF-mutated metastatic melanoma

August 14, 2019
About one-third of patients with unresectable or metastatic melanoma with a BRAF V600E or BRAF V600K mutation who received first-line dabrafenib…
In the JournalsPerspective

Ibrutinib plus rituximab 'more effective and less toxic' than chemoimmunotherapy for chronic lymphocytic leukemia

July 31, 2019
A combination of ibrutinib and rituximab improved PFS and OS compared with standard

The University of Texas MD Anderson Cancer Center ranked best cancer hospital in nation

July 30, 2019
The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country. MD Anderson tops U.S
Meeting News

Serum-based biomarker test yields positive diagnostic accuracy for Crohn’s disease

July 10, 2019
SAN DIEGO — The Mucosal Healing Index, a serum-based biomarker assay, demonstrated efficacy in identifying mucosal inflammation and similar…

Discussing stroke risk with younger patients

June 12, 2019
The recent deaths of actor Luke Perry aged 52 years, and director John Singleton, aged 51 years, from strokes shone a brighter spotlight on the fact…
Meeting NewsPerspective

Majority of gynecologic oncologists, female and male, experience sexual harassment, survey shows

June 11, 2019
CHICAGO — More than 70% of female gynecologic oncologists reported encountering sexual harassment during training or in practice, according to…
Meeting NewsPerspective

Enfortumab vedotin induces responses in advanced urothelial cancer

June 11, 2019
CHICAGO — The investigational therapy enfortumab vedotin demonstrated an objective response rate of 44% among a cohort of patients with locally…
Meeting NewsPerspective

Pembrolizumab for advanced hepatocellular carcinoma reduces mortality risk in 'technically ... negative study'

June 10, 2019
CHICAGO — Patients with previously treated advanced hepatocellular carcinoma demonstrated reduced risk for death and improved PFS with the…
Meeting NewsPerspective

Pediatric tumor-sequencing trial finds higher rate of targetable alterations than expected

May 17, 2019
Genetic sequencing of tumors among children with refractory cancer led to about a quarter of those tested being matched with therapies targeting…
FDA News

Extension catheter for complex PCI procedures launched

May 17, 2019
Medtronic announced that it has launched an extension catheter that was approved by the FDA in March to provide backup support and access in complex…
Meeting NewsPerspective

Entrectinib induces ‘rapid and durable’ responses in pediatric tumors with gene fusions

May 16, 2019
Children with central nervous system or other solid tumors with specific gene fusions responded to treatment with the investigational tyrosine kinase…
Cover Story

A New Era for TAVR

Cardiology Today's Intervention, May/June 2019
Presentation of the PARTNER 3 and Evolut Low Risk trials at the American College of Cardiology Scientific Session in March was met with a standing…
In the JournalsPerspective

Alpelisib plus fulvestrant extends PFS in PIK3CA-mutated advanced breast cancer

May 15, 2019
Patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative
In the Journals

EXTEND: Initiating alteplase after traditional treatment window may reduce neurologic deficits

May 8, 2019
Patients with salvageable brain tissue who were assigned alteplase between 4.5 and 9 hours after the onset of an ischemic stroke or when they woke up…
Meeting News

AF ablation volume correlated with complication, mortality rates

May 8, 2019
SAN FRANCISCO — Patients who receive atrial fibrillation ablation at hospitals that perform the procedures infrequently are at elevated risk…